Cargando…
Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia
Methylseleninic acid (MSeA) is a monomethylated selenium metabolite theoretically derived from subsequent β-lyase or transamination reactions of dietary Se-methylselenocysteine that has potent antitumor activity by inhibiting cell proliferation of several cancers. Our previous studies showed that MS...
Autores principales: | Sinha, Indu, Allen, Joshua E, Pinto, John T, Sinha, Raghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987075/ https://www.ncbi.nlm.nih.gov/pubmed/24515947 http://dx.doi.org/10.1002/cam4.198 |
Ejemplares similares
-
REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by
axonal injury
por: Morquette, B, et al.
Publicado: (2015) -
Age-dependent changes in the protein expression levels of Redd1 and mTOR in the gerbil hippocampus during normal aging
por: CHOI, HEE-SOO, et al.
Publicado: (2016) -
The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013) -
THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC ACID ON VARIOUS CANCER CELLS
por: Varlamova, Elena G., et al.
Publicado: (2021) -
Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)